心肾综合征中心血管危险的生物学标记
摘要
慢性。肾脏病(chronic kidney disease,CKD)已经成为了世界性的公共卫生问题,心血管疾病(cardiovascular disease,CVD)是CKD患者的主要并发症和首要致死原因。
出处
《医学新知》
CAS
2011年第3期161-164,167,共5页
New Medicine
参考文献43
-
1Ronco C, Haapio M, HDuSe A A, et al. Cardiorenal syndrome [ J ]. J Am Coil Cardio1,2008,52(19) :1527-1539.
-
2Iwanaga Y, Nishi I, Furuichi S, et al. B - type natriuretic peptide strongly reflects diastolic wall stress in patients with chronic heart failure:Comparison between systolic and diastolic heart failure[ J]. J Am Coil Cardiol 2006,47:742-748.
-
3McCullough P A ,Sandberg K R. B -type natriuretic peptide and re- nd disease[ J]. Heart Fail Rev,2003,8:355-358.
-
4Clerico A,Fontana M,Zyw L,et al. Comparison of the diagnostic ac- curacy of brain natriuretic peptide(BNP) and the N -terminal part of the propeptide of BNP immunoassays in chronic and acute heart fail- ure : A systematic review [ J ]. Clin Chem, 2007,53 : 813-822.
-
5Naganuma T, Sugimura K, Wada S, et al. The prognostic role of brain natriuretic peptides in hemodialysis patients [ J 3. Am J Nephrol, 2002,22:437-444.
-
6Wang A Y, Lam C W, Yu C M, et al. N - Terminal pro - brain natfi- uretic peptide:An independent risk predictor of cardiovascular con- gestion, mortality, and adverse cardiovascular outcomes in chronicperitoneal dialysis patients [ J ]. J Am Soe Nephrol, 2007,18 : 321- 330.
-
7NACB Writing Group. National Academy of Clinical Biochemistry la- boratory medicine practice guidelines:Use of cardiac troponin and B - type natriuretic peptide or N - terminal proB - type, natriuretic peptide for etiologies other than acute coronary syndromes and heart failure [ J ]. Clin Chem,2007 ,53 :2086-2096.
-
8deFilippi C, van Kimmenade R R, Pinto Y M. Amino - terminal pro -B -type natriuretic peptide testing in renal disease[ J]. Am J Car- dio1,2008,101:82-88.
-
9van Kimmenade R R,Januzzi J L Jr,Bakker J A,et al. Renal clear- ance of B - type natriuretic peptide and amino terminal pro - B - type natriuretic peptide a mechanistic study in hypertensive subjects [J]. J Am Coil Cardiol,2009 ,53 :884-890.
-
10Niizuma S, Iwanaga Y, Yahata T, et al. Impact of left ventricular end - diastolic wall stress on plasma B - type natriuretic peptide in heart failure with chronic kidney disease and end - stage renal disease [ J ]. Clin Chem,2009,55 : 1347-1353.
-
1曹广亚,周运恒.急性肾损伤的早期检测标志物研究进展[J].检验医学,2011,26(4):281-284. 被引量:2
-
2李宁,任长虹,吉训明.脑外伤生物标记物的研究进展[J].中国医药,2012,7(9):1188-1190. 被引量:4
-
3王瑜元(综述),陆福明(审校).慢性移植物肾病生物学标志物的研究进展[J].国际泌尿系统杂志,2009,29(3):385-387.
-
4苏圆圆,廖晓辉.新型急性肾损伤标志物在慢性肾脏病中的作用[J].现代医药卫生,2015,31(13):1971-1973.
-
5吴建华,范亚平.梗阻性肾病肾损伤生物标志物研究进展[J].国际泌尿系统杂志,2015,35(6):958-960. 被引量:3
-
6吴建华(综述),范亚平(审校).心肾综合征相关生物标志物[J].国际泌尿系统杂志,2013,33(4):567-572.
-
7张冲,向军军.电针与干细胞移植治疗脊髓损伤的研究进展[J].中西医结合心脑血管病杂志,2016,14(20):2390-2393.
-
8吴晓云,瞿晓红,臧旺福.心脏术后急性肾损伤早期监测的新生物学指标[J].国际检验医学杂志,2009,30(3):260-261. 被引量:2
-
9徐欣晖,钱家麒.生物标志物与急性肾功能衰竭早期预测[J].国外医学(泌尿系统分册),2005,25(2):223-226.
-
10王涛(综述),张薇(审校).急性肾损伤的生物学标记的最新研究进展[J].国际泌尿系统杂志,2010(1):107-110.